Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, double blind, placebo-controlled, superiority clinical trial
was to assess clinical efficacy of potassium canrenoate - canrenone in rapid conversion of
atrial fibrillation to sinus rhythm.